Slides
Page 1
THE CHEMOURS COMP ANY INVEST OR PRESENT A TION February 25, 2026
Page 2
This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward- looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized, such as guidance relying on models based upon management assumptions regarding future events that are inherently uncertain. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties including the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, our ability to maintain an effective internal control over financial reporting and disclosure controls and procedures, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, changes in regulations in the U.S. or other jurisdictions that could impose tariffs or additional costs on products either sell or need to purchase, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, efforts to resolve outstanding or potential litigation, including claims related to legacy PFAS liabilities, plans for dividends, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to develop and commercialize new products or technologies and obtain necessary regulatory approvals, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, among others, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements also may involve risks and uncertainties that are beyond Chemours' control. Matters outside our control, including general economic conditions, geopolitical conditions, changes in laws and regulations in the U.S. or other jurisdictions in which we operate, and global health events and weather events, among others, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our documents filed with or furnished to the U.S. Securities and Exchange Commission (“SEC”), including in our Annual Report on Form 10-K for the year ended December 31, 2025. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law. We prepare our financial statements in accordance with Generally Accepted Accounting Principles (GAAP). Within this presentation, we may make reference to Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow, Free Cash Flow Conversion, Total Debt Principal, Net Debt and Net Leverage Ratio which do not have any standardized meaning as prescribed by GAAP and are considered non-GAAP financial measures. The Company includes these non-GAAP financial measures because management believes they are useful to investors in that they provide for greater transparency with respect to supplemental information used by management in its financial and operational decision making. Management uses Adjusted Net Income, Adjusted EPS, Adjusted EBITDA Margin, and Adjusted EBITDA, which adjust for (i) certain non-cash items, (ii) certain items we believe are not indicative of ongoing operating performance or (iii) certain nonrecurring, unusual or infrequent items to evaluate the Company's performance in order to have comparable financial results to analyze changes in our underlying business from period to period. Additionally, Free Cash Flow, Free Cash Flow Conversion, Total Debt Principal, Net Debt and Net Leverage Ratio are utilized as liquidity measures to assess the cash generation of our businesses and on-going liquidity position. These measures may not be comparable to similar measures presented by other companies and should not be viewed as a substitute for measures reported under GAAP . Accordingly, the Company believes the presentation of these non-GAAP financial measures, when used in conjunction with GAAP financial measures, is a useful financial analysis tool that can assist investors in assessing the Company's operating performance and underlying prospects. This analysis should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP . This analysis, as well as the other information in this presentation, should be read in conjunction with the Company's financial statements and footnotes contained in the documents that the Company files with the SEC. The non-GAAP financial measures used by the Company in this presentation may be different from the methods used by other companies. The Company does not provide a reconciliation of certain forward-looking non-GAAP financial measures to the most directly comparable GAAP reported financial measures on a forward-looking basis because it is unable to predict with reasonable certainty the ultimate outcome of unusual gains and losses, potential future asset impairments and pending litigation without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period. For more information on the non-GAAP financial measures, please refer to the reconciliation tables beginning on page 30 of this presentation and materials posted to the Company's website at investors.chemours.com. This presentation has been prepared by the Company for information purposes only and is being furnished on a confidential basis solely for use by the recipient in making its own evaluation of the Company and its business, assets, financial condition and prospects. Safe Harbor Statement and Other Matters 2
Page 3
3 01 Company Overview 02 Strategic Progress 03 Financial Update 04 Appendix Agenda
Page 4
COMP ANY OVERVIEW 1
Page 5
TT TiO2 and other minerals 42% Opteon refri. 22% Freon refri. 7% FP&O 6% Other Segment 1% Advanced Materials 13% Performance Solutions 9% APM TSS $145 6% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% $- $500 $1,000 $1,500 $2,000 $2,500 $3,000 $2,429 Adj. EBITDANet Sales Titanium Technologies (TT) $670 32% 0% 50% 100% 150% 200% 250% $- $500 $1,000 $1,500 $2,000 $2,500 $3,000 $2,066 Net Sales Adj. EBITDA Thermal & Specialized Solutions (TSS) $742 0% 10% 20% 30% 40% 50% $- $500 $1,000 $1,500 $2,000 $2,500 $3,000 $5,808 0 2000 4000 6000 Adj. EBITDA1Net Sales North America 46% Asia Pacific 21% EMEA 20% Latin America 13% Geographical Breakdown Source: Company SEC filings 1 Non-GAAP measures, including Adjusted Net Income, Adjusted EPS, Adjusted EBITDA Margin, and Adjusted EBITDA referred to througho ut, principally exclude the impact of recent litigation settlements for legacy environmental matters and associated fees, in addition to other unallocated items. Adjusted EBITDA excludes net income attributable to noncontrolling interests, net interest expense, depreciation and a mortization, and all remaining provision for income taxes from Adjusted Net Income. See Appendix for a reconciliation to the mos t comparable measures reported in accordance with GAAP. Global Business Mix (All $’s on a trailing twelve-month basis as of December 31, 2025, in millions) $108 9% 0% 50% 100% 150% 200% $- $500 $1,000 $1,500 $2,000 $2,500 $3,000 Adj. EBITDA Margin1 $1,263 Adj. EBITDANet Sales Advanced Performance Materials (APM)Total Chemours 5 13% Chemours Has a Collection of Industry-Leading Businesses 1 2 3
Page 6
DATA CENTERS • Leading, global provider of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents • Category leader in low global warming potential (“GWP”) refrigerant technology, Opteon − Cost-advantaged process technology at Corpus Christi, TX facility; 40% capacity expansion completed in late 2024 − Robust international patent portfolio for products and methods, providing protection until the early to mid-2030s with investments underway towards continued innovation in next generation refrigerant − Made meaningful progress towards commercializing two- phase immersion cooling during 2025 TSS Key End Markets Product Type1Geography1 Adj. EBITDA Margin2 of 32% TSS Market Strength 1 Data reflects Net Sales for the trailing twelve months ended December 31, 2025. 2Adjusted EBITDA Margin is a non-GAAP measure. See Appendix for a reconciliation to the most comparable measures reported in acco rdance with GAAP. North America 54% Asia Pacific 11% EMEA 18% Latin America 16% Opteon Refrigerants 61% Freon Refrigerants 21% Foam, Propellants & Other 18% 1 6 Thermal & Specialized Solutions – Business Summary
Page 7
Innovation Through Two-Phased Immersion Cooling withOpteon Source: Internal Estimates, ING THINK 1 Based on relative heat transfer coefficients. The Technology Key Advantages Solution for future higher capacity computing energy and performance demands • Low water usage • Low GWP • Low asset footprint • Low energy usage • Low maintenance • Over 95% of data centers use traditional air- and water- cooled technologies • Data centers are highly energy-intensive, with over 40% of energy dedicated to cooling IT equipment • A mid-sized US data center consumes approximately 300,000 gallons of water per day • Next-generation CPU to GPU transition supporting AI technology expansion is driving the industry to evaluate liquid cooling • Little to no water usage • Direct-to-chip and single-phase immersion cooling require additional air-cooled or secondary refrigerant loops and equipment • Superior heat absorption performance: ~100x better than air, ~10x better than single-phase immersion cooling1 • Up to a 90% reduction in cooling energy consumption, which equates to a potential 40% reduction in total data center energy consumption • Simplified maintenance compared to single-phase immersion cooling • Lower total cost of ownership and greater flexibility compared to direct-to-chip and single-phase immersion cooling Key Market Drivers Why Two- Phase Immersion Cooling? 1 7
Page 8
Source: Internal Estimates Note: US ~ 304 MMT CO2eq EU ~ 182 MMT CO2eq. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2035 2037 2039 PERCENT OF PHASE DOWN2 AIM F-Gas RevisionF-Gas Kigali A1 Kigali A5 Montreal Protocol / Kigali US AIM Act EU F-Gas Regulation • Chemours is pleased to have achieved its 2025 goal with its low GWP products delivering more than 350 million tons of avoided global CO2-equivalent emissions • The AIM Act empowers the EPA to reduce US HFC production and consumption ~85% by 2036, driving customers to transition to low GWP HFO refrigerants, including OpteonTM as one of two viable choices • The phasedown is organized in a stepwise manner, utilizing an allowance allocation and trading program; GWP stepdown based on CO2eq allocation 2024 Stepdown US: 30% (40% cumulative) EU1:21% (76% cumulative) 2026 Technology Transition EPA stationary equipment sell-through date moved to 1/1/2026 Low GWP Products as % of Total Refrigerants Volume Region FY 2023 FY 2024 EMEA 78% 89% N. America 27% 34% 8 1 Favorable Regulatory Trends Accelerating Opteon Adoption
Page 9
1 Source: Internal Estimates, Nvidia GPU Roadmap, “Syska, Chemours, Liquidstack TCO Study V1.1” Market Adoption is Subject to Applicable Regulatory Approval Chemours’ partnership with Navin Fluorine since May 2025 is expected to establish initial capacity and enable adoption of two-phase immersion cooling, a key first step in the pathway to serve a growing market. 1 Liquid Cooling Market Adoption • Data center chip technology advancements driven by artificial intelligence (AI) is requiring increased power consumption, heat emittance, and server rack density1 • New liquid cooling technologies are essential to optimize performance of next generation chips paired with the lowest total cost of ownership to other alternatives • Chemours has recently expanded its liquid cooling offering to also include two-phase fluids for direct-to-chip and immersion cooling applications to provide a suite of offerings to address data center cooling needs in an evolving market • Chemours’ pathway to serve the market aligns with the cadence below: − Lab testing and server compatibility to qualify fluid − Field trial of a small system to confirm onsite performance − Initial commercial deployment of liquid cooling systems, paired with new infrastructure builds − Adoption in targeted data centers Advancements in chip technology are expected to drive the need for liquid cooling tech over time 9
Page 10
1 Source: OCP Cold Plate and Direct to Chip Working Groups & Expert Interviews 2 Source: “Chemours, Syska, Liquidstack TCO Study V1.1”, Expert Interviews, & Internal Testing Two-Phase Immersion Cooling Key Advantages 2 Solution for future higher density computing energy and performance demands • Low Total Cost of Ownership • Low water usage • Low GWP • Low asset footprint • Low energy usage • Low maintenance Two-Phase Direct to Chip Key Advantages 1 Enabling the use of higher efficiency and higher performing two-phase liquids in direct-to-chip applications • High heat transfer rates • High thermal capacity • Low global warming potential (GWP) • Retrofittable in existing data centers • Low energy usage • Stable temperatures during operation Electronic equipment is placed inside a semi hermetic tank filled with Opteon 2P50 1 The heat from the electronic equipment causes the fluid to boil 2 3 Vapor rises and condenses back to a liquid when it makes contact with the condenser coil 4 The fluid returns to the pool in a passive cycle 1 3 2 4 Chilled Opteon SF33 thermal management fluid circulates into the server rack The fluid boils, exiting the heat exchanger as a vapor A specialized cold plate located directly on top of the chip is used to transfer heat to the fluid The vapor returns to a to be condensed back to a liquid and recirculated back to the chip Key technology to bridge from single-phase direct-to-chip to two-phase immersion cooling Preferred solution to provide lowest total cost of ownership for high -performance computing hardware 1 Innovation Through Two-Phase Liquid Cooling Fluids 10
Page 11
A global leader2 in TiO2 production – 3 TiO2 plants, 6 production lines – Global sales, marketing and technical teams Strong brand reputation – Ti-Pure sold to approximately 500 customers globally – Reliable supply, exceptional quality Industry-leading manufacturing cost position – Unique chloride technology – Feedstock flexibility – Expanded manufacturing flexibility to respond to customer demand TT Key End Markets Major Segments 1Geography 1 North America 42% Asia Pacific 19% EMEA 23% Latin America 15% Global Presence in Major Segments 1 Data reflects Net Sales for the trailing twelve months ended December 31, 2025. 2 TiO2 market share statistics based on internal estimates Recent strategic actions to optimize manufacturing circuit in order to drive prospective margin improvement Coatings Plastics Papers Coatings – architectural, industrial, automotive Plastics – rigid/flexible packaging, PVC pipe/windows Papers – laminate papers, coated paper/paperboard, sheet Improving the quality of earnings by utilizing our industry-leading manufacturing circuit and implementing a cost leadership strategy as part of our TT Transformation Plan 11 2 Titanium T echnologies – Business Summary
Page 12
Leader Across a diverse range of high-end materials ~900 Customers & distributors; no customer representing >10% of sales1 High Earnings upside through continued specialty application developments $1.3B Sales2 $108M Adjusted EBITDA3 1 Excluding external monomer sales. 3 Data reflects Net Sales for the trailing twelve months ended December 31, 2025. 2 Data reflects Adjusted EBITDA for the trailing twelve months ended December 31, 2025. Adjusted EBITDA is a non-GAAP measure. See Appendix for a reconciliation to the most comparable measure reported in accordance with GAAP. Revenue Contribution by Portfolio3 Advanced Materials 60% Performance Solutions 40% Diverse Revenue Base3Global Footprint3 APM Opportunity • Expanding our market-leading position with select investments supporting high-growth platforms • Positioned to capture secular growth, projected to accelerate through the decade North America 38% Asia Pacific 42% EMEA 16% Latin America 4% Electronics & Communications TransportationChemical Processing Consumer Goods Energy & Industrial Medical Others 12 3 Advanced Performance Materials – Business Summary
Page 13
Key Considerations ➢ Resolves all environmental claims, including those related to PFAS, across four current and former operating sites (Chambers Works, Parlin, Pompton Lakes and Repauno) and all statewide PFAS claims ➢ Chemours’ discounted share of settlement payments is ~$270 million, reflecting a 25-year payment time frame, excluding insurance recoveries ➢ 2025 Insurance proceeds MOU between companies provides $150 million1 to Chemours to be used to fund NJ settlement payments ➢ No out-of-pocket NJ settlement payments for Chemours expected through at least 2030 from combination of insurance proceeds (~$150 million1) and existing escrow funds (~$50 million) ➢ The present value of payments remaining after 2030 by Chemours for the New Jersey settlement is approximately $80 million ➢ $16.5 million allocated to resolve AFFF/PFAS litigation unrelated to existing sites ➢ Continues cooperation between Companies to resolve legacy litigation matters under the framework of existing 2021 MOU cost sharing arrangement 1Amounts are presentedon an undiscounted basis. Over the first 5 years, Chemours is obligated to fund $200 million of gross settlement payments,of which $150 million will be funded by the insurance proceeds MOU and expect the remaining$50 million to be funded from existing restrictedcash held by Chemours. 13 Strengthening the Long-T erm: Resolving Legacy Liabilities Advanced a Settlement with the state of New Jersey to comprehensively resolve environmental claims including PFAS
Page 14
• In July 2023, Chemours announced the strategic closing of its TiO2 manufacturing site in Kuan Yin, Taiwan. The closing of the facility was part of the Company’s broader strategy to right-size its operational footprint and reduce costs in the Titanium Technologies business • Following an active marketing and sale campaign, Chemours announced in January 2026 the signing of a definitive agreement to sell the remaining land formerly associated with the manufacturing site, for gross proceeds of $360 million, or net proceeds of ~$300 million. Chemours expects to use the proceeds from the sale to reduce debt obligations and further strengthen its balance sheet • The property will be sold to an ownership group consisting of Century Wind Power Co., Ltd., Century Iron & Steel Industrial Co., Ltd., and Century Huaxin Wind Energy, Co., Ltd. in a series of transactions which are expected to substantially close and fund by mid-2026, subject to local regulatory approval, inclusive of environmental conditions • The announcement marks a key achievement in the Pathway to Thrive strategy, consistent with the Company's commitment to drive shareholder value through effective Portfolio Management 14 Taiwan Land Sale Overview
Page 15
STRA TEGIC PROGRESS P A THWA Y TO THRIVE 2
Page 16
16 Balanced & Disciplined Capital Allocation To Create Shareholder Value Expanding Free Cash Flow Conversion & Net Leverage of Approximately 3x Operational Excellence ❑Manufacturing excellence as a basis for success ❑Improved and standardized operating model for consistent execution ❑Continuous improvement to adapt to changing markets Strengthening the Long-Term ❑Measurable progress on resolving legacy liabilities in the interest of stakeholders ❑Responsible manufacturing practices ❑Targeted policy efforts Enabling Growth ❑Investing smartly in selected growth projects ❑Commercial effectiveness to drive sales growth ❑Innovation and new product development Portfolio Management ❑Holistic portfolio analysis focused on distinct value creation metrics ❑Shift product mix to higher value applications in growing end markets ❑Optimize asset footprint Targeting >$250M cost reduction from 2024 to 2027 Recognizing criticality of our chemistriesDriving shareholder value Targeting >5% Sales CAGR from 2024 to 2027 Our Strategy PATHWAY TO THRIVE
Page 17
Progress Achieved to Date PATHWAY TO THRIVE Balanced & Disciplined Capital Allocation To Create Shareholder Value Operational Excellence ✓ Delivered a minimum of $125 million of cost savings within Chemours’ control during 2025 across all areas of the company ✓ Advanced the Chemours Business System rollout, embedding Lean principles supported by our Manufacturing COE to drive continuous improvement in safety, quality, and reliability ✓ Corpus Christi, TX capacity expansion to support low GWP regulatory transitions for stationary AC equipment under the U.S. AIM Act Strengthening the Long-Term ✓ Agreed to a proposed Judicial Consent Order with the State of New Jersey to resolve all environmental claims, including PFAS statewide Results of key advocacy efforts: ✓ EU ITRE committee commissioned study highlights critical role of fluoropolymers and f-gases1 ✓ EPA starts priority review for new chemicals supporting data center projects; including liquid cooling2 Enabling Growth ✓ Continued double-digit growth with 37% YoY quarterly growth in Opteon Refrigerants, with an advantaged market position to secure aftermarket share ✓ Implemented global TiO2 pricing increase reflecting Chemours’ value in reliability and sustainability ✓ Grew APM Performance Solutions sales through key data center end markets ✓ Successful qualification of Chemours’ two-phase immersion cooling fluid by Samsung Electronics Portfolio Management ✓ Progressed APM European asset review, through the exit of the Villers-St. Paul site and the wind down of SPS Capstone business at the end of the Q3, driving opportunistic sales in 2025 ✓ Agreed to sell former Kuan Yin TiO2 site for gross proceeds of $360 million, ~$300 million, net ✓ Shifted aspects of TT’s mining operations to prioritize cash flow generation 17 1 The Per- and polyfluoroalkyl substances and their role as enablers in the competitiveness of European industry 2 EPA Prioritizes Review of New Chemicals Used in Data Center Projects, Supporting American Manufacturing and Technological Advancement
Page 18
FINANCIAL UPDA TE 3
Page 19
19 Fourth Quarter & Full Year 2025 Highlights 1Adjusted EBITDA is a non-GAAP measure. See Appendix for a reconciliation to the most comparable measure reported in accordance with GAAP. Generated $1.3B in Net Sales and $128M in Adjusted EBITDA1 in 4Q25, driving Net Sales of $5.8B and Adjusted EBITDA1 of $742M for the year Announced the sale of the former Kuan Yin TiO2 site on January 15, 2026, for $360 million in gross proceeds, approximately $300 million, net Achieved 37% 4Q25 and 56% full year 2025 YoY Net Sales growth for Opteon Refrigerants in TSS, reflecting continued strong adoption Implemented a global TiO2 price increase which became effective December 1, 2025
Page 20
Full Year 2025 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) 1 Net (Loss) / Income attributable to The Chemours Company. 2 Non-GAAP measures, including Adjusted Net Income, Adjusted EPS and Adjusted EBITDA referred to throughout, principally exclude the impact of recent litigation settlements for legacy environmental matters and associated fees, in addition to other unallocated items. Please refer to the attached "GAAP Net (Loss) IncomeAttributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited)” table. 3 Calculation based on diluted share count. 4 Adjusted EBITDA excludes net income attributable to noncontrolling interests, net interest expense, depreciation and amortization, and all remaining provision for income taxes from Adjusted Net Income. Please refer to the attached “GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited)” table. 5 As previously disclosed in the first quarter of 2025, certain prior period amounts have been revised to correct for certain immaterial errors as further described in our Annual Report on Form 10-K for the year ended December 31, 2025. 6 2024 Cash Flow included $606 million of restricted cash and cash equivalents related to the US Public Watern System Class Action Suit Settlement. 7Free Cash Flow and FCF Conversion are non-GAAP measures. See Appendix for a reconciliation to the most comparable measure reported in accordance with GAAP. 20 FY25 FY24 5 Y-o-Y ∆ Net Sales $5,808 $5,782 $26 Net (Loss) / Income 1 ($386) $69 ($455) Adj. Net Income 2 $143 $179 ($36) EPS 3 ($2.57) $0.46 ($3.03) Adj. EPS 2,3 $0.95 $1.19 ($0.24) Adj. EBITDA 2,4 $742 $768 ($26) Operating Cash Flow 6 $264 ($633) $897 Capex ($213) ($360) ($147) Free Cash Flow7 $51 ($993) $1,044 FCF Conversion7 7% (129)% 136%
Page 21
4Q25 4Q24 5 Y-o-Y ∆ 3Q255 Q-o-Q ∆ Net Sales $1,329 $1,359 ($30) $1,495 ($166) Net (Loss) / Income1 ($47) ($11) ($36) $46 ($93) Adj. Net Income 2 $7 $14 ($7) $26 ($19) EPS 3 ($0.31) ($0.08) ($0.39) $0.31 ($0.62) Adj. EPS 2,3 $0.05 $0.09 ($0.04) $0.17 ($0.12) Adj. EBITDA 2,4 $128 $168 ($40) $189 ($61) Operating Cash Flow $137 $138 ($1) $146 ($9) Capex ($45) ($109) ($64) ($41) $4 Free Cash Flow6 $92 $29 $63 $105 ($13) FCF Conversion6 72% 17% 55% 56% 16% Fourth Quarter 2025 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) 21 1Net (Loss) / Income attributable to The Chemours Company. 2Non-GAAP measures, including Adjusted Net Income, Adjusted EPS and Adjusted EBITDA referred to throughout, principally exclude the impact of recent litigation settlements for legacy environmental matters and associated fees, in addition to other unallocated items. Please refer to the attached "GAAP Net (Loss) IncomeAttributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited)” table. 3Calculation based on diluted share count. 4Adjusted EBITDA excludes net income attributable to noncontrolling interests, net interest expense, depreciation and amortization, and all remaining provision for income taxes from Adjusted Net Income. Please refer to the attached “GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited)” table. 5As previously disclosed in the first quarter of 2025, certain prior period amounts have been revised to correct for certain immaterial errors as further described in our Annual Report on Form 10-K for the year ended December 31, 2025. 6Free Cash Flow and FCF Conversion are non-GAAP measures. See Appendix for a reconciliation to the most comparable measure reported in accordance with GAAP.
Page 22
$768 $742 ($18) $67 $22($96) FY24 Price Volume Cost/Other Currency FY25 Adjusted EBITDA Bridge: FY25 versus FY24 ($ in millions) 22 See reconciliation of Non-GAAP measures in the Appendix 1 Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025. 2 Excluding litigation settlements recognized in the years ended December 31, 2024 and December 31, 2025 1 Price Impacts: ($18) million driven by lower TiO2 pigment (TT) pricing globally partially offset by higher pricing in TSS primarily driven by stronger Opteon Refrigerant blends aftermarket demand and strong pricing in APM in connection with strong sales execution for our SPS Capstone product line closure in the third quarter Volume Impacts: $67 million driven by increased volumes in TSS’s Opteon Refrigerant blends associated with the AIM Act stationary transition, slightly offset by lower volumes in APM tied to the recent closure of APM's Advanced Materials SPS Capstone product line in the third quarter Cost/Other: ($96) million driven by lower cost absorption tied to lower production levels concentrated in APM and TT, partially offset by global net cost reduction efforts2 Currency: $22 million primarily driven by favorable currency dynamics within the TT and TSS business units
Page 23
Adjusted EBITDA Bridge: 4Q25 versus 4Q24 ($ in millions) 23 $168 $128 $13 ($10) $13($56) 4Q24 Price Volume Cost/Other Currency 4Q25 See reconciliation of Non-GAAP measures in the Appendix 1 Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025. 1 Price Impacts: $13 million due to higher pricing in TSS primarily driven by stronger Opteon Refrigerant blends mix paired with higher pricing associated with opportunistic Freon Refrigerant sales and higher pricing in APM, partially offset by lower TiO2 pigment pricing (TT) globally Volume Impacts: ($10) million primarily driven by decreased volumes in TT and APM related to muted demand environments in these segments, partially offset by increased TSS volume Cost/Other: ($56) million primarily driven by lower cost absorption tied to lower production levels concentrated in APM and TT, a non-cash inventory charge in APM, partially offset by global net cost reduction efforts6 Currency: $13 million primarily driven by favorable currency dynamics within the TT and TSS business units
Page 24
$2,680 $2,572 $2,429 FY23 FY24 FY25 TT ($ in millions unless otherwise noted) 24 Full Year Segment Summary $683 $571 $670 FY23 FY24 FY25 37% 31% 32% Net Sales1 Adjusted EBITDA and Margin 1 (%) $1,851 $1,831 $2,066 FY23 FY24 FY25 TSS TSS 11% 12% 6% 19% 12% 9% 1 See reconciliation of Non-GAAP measures in Appendix. Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025. APM $1,462 $1,326 $1,263 FY23 FY24 FY25 TT $290 $301 $145 FY23 FY24 FY25 APM $273 $160 $108 FY23 FY24 FY25
Page 25
TT $651 $632 $561 4Q23 4Q24 4Q25 Quarterly Segment Summary ($ in millions unless otherwise noted) 25 $122 $122 $128 4Q23 4Q24 4Q25 32% 31% 29% Net Sales1 Adjusted EBITDA and Margin 1 (%) $380 $390 $444 4Q23 4Q24 4Q25 TSS TSS 10% 11% 4% 12% 15% 4% 1 See reconciliation of Non-GAAP measures in Appendix. Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025. APM $326 $324 $312 4Q23 4Q24 4Q25 TT $64 $70 $23 4Q23 4Q24 4Q25 APM $40 $47 $12 4Q23 4Q24 4Q25
Page 26
$613 Unrestricted $670 Unrestricted $52 Restricted $137 ($45) ($15) ($18) $54 Restricted 3Q25 Cash Balance Operating Cash Flows Capex Cash to Shareholders Other 4Q25 Cash Balance Liquidity Position as of December 31, 2025 ($ in millions unless otherwise noted) 7 26 11 $4.2B $3.5B 4.7x Gross Debt TTM Net Leverage 6 Net Debt 5 $1.6BTotal Liquidity 4 2 1 Total cash balances include $54 million and $52 million of restricted cash and restricted cash equivalents on Chemours’ Balance Sheets as of December 31, 2025 and September 30, 2025, respectively. Restricted cash of $52 million at the end of the third quarter and $54 million at the end of the fourth quarter includes cash and cash equivalents held in escrow under the terms of the Memorandum of Understanding (MOU) related to potential future legacy liabilities. 2 Cash to shareholders reflects approximately $15 million in dividends paid to shareholders during the fourth quarter of 2025. 3 Other primarily includes FX impacts on cash net of debt repayments, partially offset by an initial earnest money deposit from the sale agreement for the remaining land at the former Kuan Yin titanium dioxide site. 4 Total liquidity is calculated as the sum of $670 million unrestricted cash and cash equivalents and $955 million of revolving credit capacity, net of outstanding letters of credit. Restricted cash and restricted cash equivalents totaling $52 million is not included in this calculation. The Company announced an amendment and extension to its credit agreement in May 2025. The amended credit facility extends commitments to 2030 with a capacity of up to $1 billion until October 2026, comprised of $780 million maturing on May 2, 2030 and $220 million on October 7, 2026. 5 Net Debt, which we also refer to herein as Total Debt Principal, Net, is calculated as gross debt less unrestricted cash and cash equivalents. 6 TTM Net Leverage reflects Total Debt Principal, Net at quarter-end divided by trailing twelve months of Adjusted EBITDA. 3 $665 $724
Page 27
x EBITDA Next Call CCR: Ba3 / BB- 31-Dec-25 FY2025 Coupon Maturity Ratings Current Call Date Price Unrestricted Cash $ 670 RCF ($1,000mm)1 - S + 125 - 200 Apr-30 NR / NR - - - EUR Term Loan B-3 (€415) 488 E + 325 Aug-28 Ba1 / BB+ 100.00 - - USD Term Loan B-4 1,050 S + 350 Oct-32 Ba1 / BB+ 101.00 - - Total Secured Debt $ 1,538 2.1 x Net Secured Debt 868 1.2 x 5.375% Senior Notes 495 5.375% May-27 B1 / BB- MWC Feb-27 100.00 5.750% Senior Notes 783 5.750% Nov-28 B1 / BB- 100.96 Nov-26 100.00 4.625% Senior Notes 620 4.625% Nov-29 B1 / BB- 101.16 Nov-26 100.00 8.000% Senior Notes 600 8.000% Jan-33 B1 / BB- MWC Jan-28 104.00 Other Debt 146 Total Debt $ 4,182 5.6 x Net Debt 3,512 4.7 x Non-controlling Interests 1 Market Cap. (24-Feb-2026) 2,763 Enterprise Value $ 6,276 7.8 x Selected Credit Metrics $mm Liquidity Analysis PF FY2025 Adjusted EBITDA2 $ 742 Unrestricted Cash $ 670 RCF Availability 1,000 (-) RCF Draw - (-) Existing Letters of Credit (45) Total Liquidity $ 1,625 Current Capitalization 27 1 Revolving commitments subject to Senior Secured Net Leverage ≤ 2.75x (stepping down to 2.50x in Q2’26 and Q3’26, and 2.0x t hereafter). 2 Adjusted EBITDA is a non-GAAP measure. See Appendix for a reconciliation to the most comparable measure reported in accordance with GAAP. Source: Bloomberg, Company Filings as of 31-Dec-2025
Page 28
APPENDIX 28
Page 29
TSS Segment Net Sales and Adjusted EBITDA (Unaudited)1 ($ in millions) % of total Net Sales ($ in millions) 29 OpteonTM Refrigerants 46% OpteonTM Refrigerants 55% FreonTM Refrigerants 32% $44 $10 FreonTM Refrigerants 25% FP&O 23% FP&O 20% 4Q24 Price/Currency Volume 4Q25 $122 $128 4Q24 Price/Currency Volume Cost/Other 4Q25 4Q25 % total refrigerants: Freon = 32% Opteon = 68% 4Q24 % total refrigerants: Freon = 41% Opteon = 59% $390 $444 1 Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025. Net Sales: The 14% year-over-year increase was driven by sustained robust demand for Opteon TM Refrigerant blends associated with the U.S. AIM Act stationary AC transition which more than compensated for lower Freon TM Refrigerant volumes. Increase in pricing was driven primarily by a favorable Opteon TM blends product mix and opportunistic sales for FreonTM Refrigerants. Adjusted EBITDA: The increase reflects higher pricing associated with the referenced OpteonTM blends mix in pricing, paired with opportunistic sales for FreonTM Refrigerant sales, partially offset by higher input costs associated with R32 in the quarter.
Page 30
TT Segment Net Sales and Adjusted EBITDA (Unaudited)1 $70 $23 4Q24 Price/Currency Volume Cost/Other 4Q25 ($ in millions) ($ in millions) 30 TiO2 95% TiO2 95% Minerals 5% $(28) $(43) Minerals 5% 4Q24 Price/Currency Volume 4Q25 $632 $561 1 Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025. Net Sales: The decrease was driven by year-over-year lower TiO2 pigment pricing and volumes that were paired with lower minerals sales. The decrease in TiO2 pigment pricing was mostly concentrated in non-western markets, while pricing declines in protected western markets were less pronounced. Adjusted EBITDA: The decline was primarily driven by referenced pricing trends combined with lower cost absorption tied to lower production levels.
Page 31
$47 $12 4Q24 Price/Currency Volume Cost/Other 4Q25 • Non-cash inventory charges • Lower utilization levels • Idling costs Advanced Materials 59% Advanced Materials 55% Performance Solutions 41% $15 ($27) Performance Solutions 45% 4Q24 Price/Currency Volume 4Q25 APM Segment Net Sales and Adjusted EBITDA (Unaudited)1 ($ in millions) % of total Net Sales ($ in millions) 31 $324 $312 1 Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025. Net Sales: 4% decrease compared to the prior-year quarter. An 8% decrease in volume was partially offset by a 4% increase in price. The decrease in volume was driven by the recent closure of APM's Advanced Materials SPS Capstone TM line, completed in the third quarter. Adjusted EBITDA: The decrease was primarily driven by short-term market weakness and a decision to prioritize cash generation in the business, leading to a non-cash inventory charge of approximately $17 million, a small idling charge, and approximately $10 million in product sales at a less favorable mix that were intended to reduce inventory and promote cash flow.
Page 32
Segment Net Sales (Unaudited)1 32 1 Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025. 2025 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Net sales by product group and segment OpteonTM refrigerants 195$ 200$ 170$ 145$ 200$ 227$ 205$ 178$ 279$ 375$ 368$ 243$ FreonTM refrigerants 185 226 170 141 173 173 146 124 97 123 98 113 Foam, propellants, and other 114 107 104 94 81 119 117 88 90 99 94 88 Total Thermal & Specialized Solutions 494 533 444 380 454 519 468 390 466 597 560 444 Titanium Dioxide 610 683 664 621 562 643 642 598 575 629 591 534 Minerals & Other 22 24 26 30 30 33 30 34 22 28 21 27 Total Titanium Technologies 632 707 690 651 592 676 672 632 597 657 612 561 Advanced materials 249 254 220 192 190 212 214 191 178 214 190 172 Performance solutions 144 140 129 134 113 133 140 133 116 132 121 141 Total Advanced Performance Materials 393 394 349 326 303 345 354 324 294 346 311 312 Performance chemicals and intermediates 30 26 18 11 14 13 14 13 11 15 12 12 Total Other Segment 30 26 18 11 14 13 14 13 11 15 12 12 Total net sales 1,549$ 1,660$ 1,501$ 1,368$ 1,363$ 1,553$ 1,508$ 1,359$ 1,368$ 1,615$ 1,495$ 1,329$ 2023 2024
Page 33
Segment Net Sales by Region (Unaudited)1 33 1 Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025. 2025 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Net sales by geographic region North America: Thermal & Specialized Solutions 292$ 319$ 258$ 207$ 271$ 308$ 256$ 194$ 233$ 336$ 316$ 241$ Titanium Technologies 262 277 273 242 246 274 270 236 267 282 252 221 Advanced Performance Materials 156 150 131 119 124 133 130 112 111 125 110 131 Other Segment 22 17 11 9 9 10 9 7 8 10 7 7 Total North America 732 763 673 577 650 725 665 549 619 753 685 599 Asia Pacific: Thermal & Specialized Solutions 53 56 42 41 39 53 55 53 53 59 69 53 Titanium Technologies 147 180 186 191 147 178 171 161 105 125 122 114 Advanced Performance Materials 147 145 133 129 105 127 138 148 115 147 138 132 Other Segment 2 4 3 3 3 2 3 3 2 3 3 3 Total Asia Pacific 349 385 364 364 294 360 367 365 275 334 332 301 Europe, the Middle East, and Africa: Thermal & Specialized Solutions 100 106 85 78 92 103 98 69 98 112 87 84 Titanium Technologies 133 147 123 116 124 130 126 131 142 156 141 128 Advanced Performance Materials 76 85 70 66 63 72 70 53 56 60 52 40 Other Segment 5 4 3 — 2 1 2 2 1 2 2 2 Total Europe, the Middle East, and Africa 314 342 281 260 281 306 296 255 297 330 282 254 Latin America (1): Thermal & Specialized Solutions 49 52 59 54 52 55 59 74 82 90 88 66 Titanium Technologies 90 103 108 102 74 95 105 104 83 94 97 99 Advanced Performance Materials 14 14 15 11 11 13 16 11 12 14 11 10 Other Segment 1 1 1 — — — — 1 — — — — Total Latin America 154 170 183 167 137 163 180 190 177 198 196 175 Total net sales 1,549$ 1,660$ 1,501$ 1,368$ 1,362$ 1,554$ 1,508$ 1,359$ 1,368$ 1,615$ 1,495$ 1,329$ 2023 2024
Page 34
Disruption & Investment Costs (Unaudited) 34 1Annual Investment costs in Liquid Cooling/Nex Generation Refrigerants approximates $15-20M spread out evenly 2024 2025 ($, millions) Q1 Q2 Q3 Q4 Total Q1 Q2 Q3 Q4 Total Disruption Costs Thermal & Specialized Solutions (TSS) Winter Storm -$ -$ -$ -$ -$ 5$ -$ -$ -$ 5$ Titanium Technologies (TT) Impacts from Altamira Outage - 8 18 - 26 - - - - - Winter Storm Impact - - - - - 7 - - - 7 Rail Impact to Ore Mix - - - - - - 15 - - 15 Operational Disruption - - - - - - 8 11 - 19 Total TT - 8 18 - 26 7 23 11 - 41 Advanced Performance Materials (APM) Higher Deferred Maintenance Costs - - - - - 5 - - - 5 Outage/Idling Costs & Related Impacts - - - - - - - 20 4 24 Total APM - - - - - 5 - 20 4 29 Corporate Expenses Internal Review Costs 12 11 2 2 27 3 1 2 - 6 Unallocated Costs (Applied in consolidation only) - TT Transformation Plan - 11 3 2 16 1 - - - 1 Other Transformation Costs - - - - - - 2 2 4 Total Unallocated - 11 3 2 16 1 2 2 - 5 Total Costs 12$ 30$ 23$ 4$ 69$ 21$ 26$ 35$ 4$ 86$ Investment Costs 1 TSS - Liquid Cooling & Next Generation Refrigerants 5$ 4$ 5$ 4$ 18$ 5$ 5$ 22$ 8$ 40$
Page 35
Segment Net Sales and Adjusted EBITDA (Unaudited)1 35 2025 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Segment Net Sales Thermal & Specialized Solutions 494$ 533$ 444$ 380$ 454$ 519$ 468$ 390$ 466$ 597$ 560$ 444$ Titanium Technologies 632 707 690 651 592 676 672 632 597 657 612 561 Advanced Performance Materials 393 394 349 326 303 345 354 324 294 346 311 312 Other Non-Reportable Segment 30 26 18 11 14 13 14 13 11 15 12 12 Total Company Net Sales 1,549$ 1,660$ 1,501$ 1,368$ 1,363$ 1,553$ 1,508$ 1,359$ 1,368$ 1,615$ 1,495$ 1,329$ Segment Adjusted EBITDA Thermal & Specialized Solutions 185$ 214$ 162$ 124$ 150$ 160$ 139$ 122$ 141$ 207$ 194$ 128$ Titanium Technologies 70 87 69 64 69 83 78 70 50 47 25 23 Advanced Performance Materials 84 81 68 40 30 45 38 47 32 50 14 12 Other Non-Reportable Segment 10 5 2 - 2 3 3 - 1 4 2 1 Corporate Expenses (45) (63) (54) (50) (55) (77) (54) (69) (57) (47) (44) (34) Segment Adjusted EBITDA Margin Thermal & Specialized Solutions 37% 40% 36% 33% 33% 31% 30% 31% 30% 35% 35% 29% Titanium Technologies 11% 12% 10% 10% 12% 12% 12% 11% 8% 7% 4% 4% Advanced Performance Materials 21% 21% 20% 12% 10% 13% 11% 15% 11% 14% 5% 4% Other Non-Reportable Segment 33% 19% 13% 0% 14% 23% 21% 0% 9% 27% 17% 10% 2023 2024 1 Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025.
Page 36
GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio1 (Page 1/2) 36 ($ in millions except per share amounts) $ amounts $ per share* $ amounts $ per share* $ amounts $ per share* $ amounts $ per share* $ amounts $ per share* Income (loss) before income taxes (67)$ 1$ 38$ (277)$ 106$ Net (loss) income attributable to Chemours (47)$ (0.31)$ (11)$ (0.07)$ 46$ 0.31$ (386)$ (2.56)$ 69$ 0.46$ Non-operating pension and other post-retirement employee benefit (income) cost (3) (0.02) 1 0.01 (4) (0.03) (10) (0.07) (3) (0.02) Exchange losses, net 4 0.03 3 0.02 1 0.01 11 0.07 9 0.06 Restructuring, asset-related, and other charges 4 0.03 7 0.05 4 0.03 58 0.39 58 0.39 Goodwill impairment charge — - — — — — — — 56 0.37 Loss on extinguishment of debt 5 0.03 1 0.01 — — 5 0.03 1 0.01 Gain on sales of assets and businesses, net — — — — (7) (0.05) (8) (0.05) (3) (0.02) Transaction costs 4 0.03 2 0.01 — — 6 0.04 2 0.01 Qualified spend recovery (7) (0.05) (4) (0.03) (13) (0.09) (42) (0.28) (26) (0.17) Litigation-related charges 19 0.13 — — 8 0.05 320 2.12 (2) (0.01) Environmental charges 20 0.13 15 0.10 13 0.09 93 0.62 15 0.10 Adjustments made to income taxes 19 0.13 6 0.04 (18) (0.12) 182 1.21 9 0.06 (Benefit from) provision for income taxes relating to reconciling items (11) (0.07) (6) (0.04) (4) (0.03) (86) (0.57) (6) (0.04) Adjusted Net Income 7$ 0.05$ 14$ 0.09$ 26$ 0.17$ 143$ 0.95$ 179$ 1.19$ Net income attributable to non-controlling interests (1) — — — — Interest expense, net 68 67 68 269 263 Depreciation and amortization (10) 81 75 80 317 292 All remaining provision for (benefit from) income taxes (27) 12 15 13 34 Adjusted EBITDA 128$ 168$ 189$ 742$ 768$ 2025 2024 2025 2025 2024 December 31, September 30, December 31, Three Months Ended Three Months Ended Year Ended 1 Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025.
Page 37
GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio1 (Page 2/2) 37 ($ in millions except per share amounts) $ amounts $ per share* $ amounts $ per share* $ amounts $ per share* $ amounts $ per share* $ amounts $ per share* Adjusted EBITDA 128$ 168$ 189$ 742$ 768$ Total debt principal 4,182$ 4,156$ Less: Cash and cash equivalents (670) (713) Total debt principal, net 3,512$ 3,443$ Net Leverage Ratio (calculated using GAAP earnings) -12.7x 32.5x Net Leverage Ratio (calculated using Non-GAAP earnings) 4.7x 4.5x Weighted-average number of common shares outstanding - basic 150,464,150 149,825,988 150,320,265 150,237,101 149,494,462 Weighted-average number of common shares outstanding - diluted 150,862,661 150,329,655 150,781,614 150,641,882 150,172,289 Basic (loss) earnings per share of common stock (2) (0.31)$ (0.08)$ 0.31$ (2.57)$ 0.46$ Diluted (loss) earnings per share of common stock (1) (2) (0.31)$ (0.08)$ 0.31$ (2.57)$ 0.46$ Adjusted basic earnings per share of common stock (2) 0.05$ 0.09$ 0.17$ 0.95$ 1.20$ Adjusted diluted earnings per share of common stock (1) (2) 0.05$ 0.09$ 0.17$ 0.95$ 1.19$ (1) In periods where the Company incurs a net loss, the impact of potentially dilutive securities is excluded from the calculation of EPS under U.S. GAAP, as their inclusion would have an anti-dilutive effect. As such, with respect to the U.S. GAAP measure of diluted EPS, the impact of potentially dilutive securities is excluded from our calculation for the three months ended December 31, 2024, September 30, 2024, and December 31, 2023, as well as the year ended December 31, 2023. With respect to the non-GAAP measure of adjusted diluted EPS, the impact of potentially dilutive securities is included in our calculation for the three months ended December 31, 2024, September 30, 2024 and December 31, 2023, as well as the year ended December 31, 2023 as Adjusted Net Income was in a net income position. (2) Figures may not recalculate exactly due to rounding. Basic and diluted (loss) earnings per share are calculated based on unrounded numbers. * Note: $ per share columns may not sum due to rounding. 2025 2024 2025 2025 2024 December 31, September 30, December 31, Three Months Ended Three Months Ended Year Ended 1. For the year ended December 31, 2024, operating cash outflows includes the release of the $606 million of cash and cash equivalents deposited in the qual ified settlement fund per the terms of the U.S. public water system settlement agreement.
Page 38
Cash flows provided by (used for) operating activities $ 137 $ 138 $ 146 $ 264 $ (633) Less: Purchases of property, plant, and equipment (45) (109) (41) (213) (360) Free Cash Flows $ 92 $ 29 $ 105 $ 51 $ (993) Adjusted EBITDA 128 168 195 742 768 Free Cash Flow Conversion 72% 17% 54% 7% (129)% 2025 2024 2025 2025 2024 Three Months Ended Year Ended December 31, September 30, December 31, GAAP Cash Flow Provided by Operating Activities to Free Cash Flows and Free Cash Flow Conversion Reconciliation 38 1 1 For the year ended December 31, 2024, operating cash outflows include the release of the 800 million of cash and cash equival ents deposited in the qualified settlement fund per the terms of the U.S. public water system settlement agreement.
Page 39
Revisions to Previously Presented Segment Net Sales, Segment Adjusted EBITDA, Adjusted Net Income and Consolidated Adjusted EBITDA1 As Reported Revision As Revised As Reported Revision As Revised Segment Adjusted EBITDA Thermal & Specialized Solutions 685$ (2)$ 683$ 576$ (5)$ 571$ Titanium Technologies 290 - 290 312 (11) 301 Advanced Performance Materials 273 1 274 161 (1) 160 Other Non-Reportable Segment 18 - 18 8 - 8 As Reported Revision As Revised As Reported Revision As Revised C orporate Expense (53)$ 6$ (47)$ (38)$ (6)$ (44)$ Litigation-related charges (299) 6 (293) (2) (6) (8) (Loss) income before income taxes (261) 13 (248) 51 (13) 38 As Reported Revision As Revised As Reported Revision As Revised As Reported Revision As Revised As Reported Revision As Revised As Reported Revision As Revised As Reported Revision As Revised (Loss) income before income taxes 1$ -$ 1$ -$ -$ -$ (261)$ 13$ (248)$ 51$ (13)$ 38$ (318)$ -$ (318)$ 127$ (21)$ 106$ Net (loss) income attributable to Chemours (10) (1) (11) (4) (1) (5) (381) 1 (380) 60 (13) 47 (238) (15) (253) 86 (17) 69 Non-operating pension and other post-retirement 1 - 1 (2) - (2) (2) - (2) (4) - (4) - - - (3) - (3) Exchange losses (gains), net 3 - 3 3 - 3 4 - 4 1 - 1 38 - 38 9 - 9 Restructuring, asset-related, and other charges 7 - 7 32 - 32 18 - 18 4 - 4 153 - 153 58 - 58 Goodwill impairment charge - - - - - - - - - - - - - - - 56 - 56 Loss on extinguishment of debt 1 - 1 - - - - - - - - - 1 - 1 1 - 1 Gain on sale of assets and businesses, net - - - (1) - (1) - - - (7) - (7) (110) - (110) (3) - (3) Transaction costs 2 - 2 - - - 2 - 2 - - - 16 - 16 2 - 2 Qualified spend recovery (4) - (4) (9) - (9) (13) - (13) (13) - (13) (54) - (54) (26) - (26) Litigation-related charges - - - - - - 299 (6) 293 2 6 8 764 (4) 760 (15) 13 (2) Enviornmental charges 15 - 15 - - - 60 - 60 13 - 13 9 - 9 15 - 15 Adjustments made to income taxes 2 4 6 - 1 1 171 8 179 (23) 5 (18) (19) 15 (4) 4 5 9 Provision for (benefit from) income taxes relating to (7) 1 (6) - - - (71) 2 (69) (3) (2) (5) (135) 1 (134) (2) (3) (6) Adjusted Net Income 10$ 4$ 14$ 19$ -$ 19$ 87$ 4$ 91$ 30$ (4)$ 26$ 425$ (3)$ 422$ 182$ (3)$ 179$ Net income attributable to non-controlling interest - - - - - - 1 - 1 - - - 1 - 1 - - - Interest expense, net 67 - 67 66 - 66 67 - 67 68 - 68 208 - 208 264 (1) 263 Depreciation and amortization 75 - 75 77 - 77 79 - 79 80 - 80 307 2 309 301 (9) 292 All remaining provision for income taxes 16 (4) 12 4 - 4 19 2 21 17 (2) 15 73 (1) 72 39 (6) 34 Adjusted EBITDA 168$ -$ 168$ 166$ -$ 166$ 253$ 6$ 259$ 195$ (6)$ 189$ 1,014$ (1)$ 1,013$ 786$ (18)$ 768$ Year Ended December 31, 2024 Year Ended December 31, 2023 Year Ended December 31, 2024 Three Months Ended June 30, 2025 Three Months Ended September 30, 2025 Three Months Ended March 31, 2025 Three Months Ended June 30, 2025 Three Months Ended September 30, 2025Three Months Ended December 31, 2024 Year Ended December 31, 2023 1 Certain prior period amounts have been revised to correct for certain immaterial errors as described in our Annual Report on Form 10-K for the year ended December 31, 2025. 39
Page 40
® 2026 CHEMOURS. ALL RIGHTS RESERVED